2,475
Views
80
CrossRef citations to date
0
Altmetric
Brief Report

DNA methylation profiles of long- and short-term glioblastoma survivors

, , , , , , , , & show all
Pages 149-156 | Received 25 Sep 2012, Accepted 21 Dec 2012, Published online: 04 Jan 2013

References

  • Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al, German Glioma Network. Long-term survival with glioblastoma multiforme. Brain 2007; 130:2596 - 606; http://dx.doi.org/10.1093/brain/awm204; PMID: 17785346
  • Hesson LB, Krex D, Latif F. Epigenetic markers in human gliomas: prospects for therapeutic intervention. Expert Rev Neurother 2008; 8:1475 - 96; http://dx.doi.org/10.1586/14737175.8.10.1475; PMID: 18928342
  • Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, et al, Cancer Genome Atlas Research Network. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010; 17:510 - 22; http://dx.doi.org/10.1016/j.ccr.2010.03.017; PMID: 20399149
  • Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012; 483:479 - 83; http://dx.doi.org/10.1038/nature10866; PMID: 22343889
  • Dallol A, Krex D, Hesson L, Eng C, Maher ER, Latif F. Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 2003; 22:4611 - 6; http://dx.doi.org/10.1038/sj.onc.1206687; PMID: 12881718
  • Hesson L, Bièche I, Krex D, Criniere E, Hoang-Xuan K, Maher ER, et al. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 2004; 23:2408 - 19; http://dx.doi.org/10.1038/sj.onc.1207407; PMID: 14743209
  • Martinez R, Martin-Subero JI, Rohde V, Kirsch M, Alaminos M, Fernandez AF, et al. A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics 2009; 4:255 - 64; PMID: 19550145
  • Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 2011; 6:692 - 702; http://dx.doi.org/10.4161/epi.6.6.16196; PMID: 21593595
  • Cahill N, Bergh AC, Kanduri M, Göransson-Kultima H, Mansouri L, Isaksson A, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2012; In press http://dx.doi.org/10.1038/leu.2012.245; PMID: 22922567
  • Roessler J, Ammerpohl O, Gutwein J, Hasemeier B, Anwar SL, Kreipe H, et al. Quantitative cross-validation and content analysis of the 450k DNA methylation array from Illumina, Inc. BMC Res Notes 2012; 5:210; http://dx.doi.org/10.1186/1756-0500-5-210; PMID: 22546179
  • Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics 2008; 24:1547 - 8; http://dx.doi.org/10.1093/bioinformatics/btn224; PMID: 18467348
  • Hill VK, Hesson LB, Dansranjavin T, Dallol A, Bieche I, Vacher S, et al. Identification of 5 novel genes methylated in breast and other epithelial cancers. Mol Cancer 2010; 9:51; http://dx.doi.org/10.1186/1476-4598-9-51; PMID: 20205715
  • Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343:1350 - 4; http://dx.doi.org/10.1056/NEJM200011093431901; PMID: 11070098
  • Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol 2009; 118:469 - 74; http://dx.doi.org/10.1007/s00401-009-0561-9; PMID: 19554337
  • Hill VK, Underhill-Day N, Krex D, Robel K, Sangan CB, Summersgill HR, et al. Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis. Oncogene 2011; 30:978 - 89; http://dx.doi.org/10.1038/onc.2010.471; PMID: 20956940

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.